Skip to main content
Clinical Trials/NL-OMON47255
NL-OMON47255
Completed
N/A

Genetic variations as predictors of outcome and toxicity in non-small-cell lung cancer patients undergoing chemoradiation or chemotherapy with platinum agents. - Pharmacogenetics lung cancer - PGx-Lung cancer

Sint Antonius Ziekenhuis0 sites350 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
lung cancer
Sponsor
Sint Antonius Ziekenhuis
Enrollment
350
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Diagnosed with NSCLC (stage II\-IV)
  • \* Age \*18 year
  • \* Received or starting with chemoradiation or chemotherapy with platinating agents (carboplatin, cisplatin)

Exclusion Criteria

  • \* Unable to give informed consent
  • \* Patients with cognitive impairment or those who are not able to read or write Dutch (because of difficulties in completing questionnaires)

Outcomes

Primary Outcomes

Not specified

Similar Trials